Elikon Venture has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Oricell Therapeutics's $70M Series B+ round in January 2026, alongside Qiming Venture Partners, Qatari sovereign wealth fund, NGS Super and 4 others. That company is in Health and bio.

What Elikon Venture invests in

• Health and bio · 1 · 100%

How Elikon Venture invests

Share is of the 1 round on Recent Funding that name Elikon Venture. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Elikon Venture portfolio companies

• OOricell Therapeutics$70MSeries B+ · Jan 2026

Most frequent co-investors

• QQiming Venture Partners1 shared round · last Jan 13, 2026
• QQatari sovereign wealth fund1 shared round · last Jan 13, 2026
• NNGS Super1 shared round · last Jan 13, 2026
• LLichen Capital1 shared round · last Jan 13, 2026
• FFrees Fund1 shared round · last Jan 13, 2026
• BBeijing Medical and Health Industry Investment Fund1 shared round · last Jan 13, 2026
• BBeijing E-town International Investment & Development1 shared round · last Jan 13, 2026

Similar investors

• AAccelia Capital1 company · 1 deal in 12 mo
• AAlly Bridge Group1 company · 1 deal in 12 mo
• AAmadeus Capital Partners1 company · 1 deal in 12 mo
• AAngel Academe1 company · 1 deal in 12 mo
• BBioGeneration Ventures1 company · 1 deal in 12 mo
• BBioGenerator Ventures1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Elikon Venture, which is a subset of its real portfolio. API: /api/v1/investors/elikon-venture (get a free API key). More: the most active VC firms and new venture capital funds.